Teva suing over generic Zoloft patents |
|
|
|
Published
:
Thu, 25 Jan 2007 00:00
|
NEW YORK (AFX) - Teva Pharmaceutical Industries Ltd. said Wednesday it filed patent infringement claims against several companies that make sertraline hydrochloride, or generic Zoloft.Pfizer Inc. lost patent protection on its antidepressant Zoloft last year.Teva filed the complaints in the U.S. District Courts of New Jersey, Delaware, Southern District of New York, and Maryland. Specifically, it mentions three patents used to make the generic drug.Israel-based Teva did not name the companies or the number of companies it is suing.Shares of Teva fell 23 cents to close at $34.73 on the Nasdaq.Copyright 2006 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2391.28 |
+2.19 (
0.09 %)
|
| SYMBOL (
2010-03-18 ) |
| LAST |
CHANGE
|
|
SABMILLER
(
12:35pm )
|
|
1925.00 |
+36.00 (
1.91 %)
|
| SYMBOL (
2010-03-18 )
|
| LAST |
CHANGE
|
|
IBM
(
4:00pm ) |
|
128.38 |
+0.62 (
0.49 %)
|
|
DUPONT
(
4:01pm ) |
|
37.07 |
+0.58 (
1.54 %)
|
| SYMBOL (
2010-03-18 )
|
| LAST |
CHANGE
|
|
|
Print this Story
FTC scrutinizes drug patent settlements 